Syngenis joins WA research heavyweights in RNA medicine push

The Sydney Morning Herald - Nov 19, 2026

Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

Read full article
More News
Business Vantage Views

Business Vantage Views is a dedicated online news network that brings to you the latest state of business and finance so that you can make the best judgment on investment and future planning.